RIMAG GROUP

Jiangxi Rimag opened lower but rallied to close up 5.21% at HKD 4.845, driven by afternoon session volume, with total turnover of HKD 3.28 million and a turnover rate of 0.24%. The stock was supported by the company's full-year turnaround to net profit of RMB 3.75 million, a reaffirmed Buy rating from TFI Asset Management, and a trustee's on-market purchase of 7.501 million shares for the share award scheme. Operating revenue grew 22.37% YoY in Q4 to HKD 226 million, while net loss narrowed 73.33% YoY, reflecting improving fundamentals. However, the stock remains over 80% below its 52-week high of HKD 24.44, trades near its 20-day MA (HKD 4.839), and is down 41.56% YTD, indicating a long road to valuation recovery.

2522.HK experienced a spike and then a sharp decline, accelerating in the afternoon session to close at HKD 4.61, down 3.56%. The sell-off was driven by intensified intraday pressure, with total volume reaching 1,427,500 shares, significantly higher than the morning session's 192,000. Q4 revenue rose 22.37% YoY to HKD 225.78 million, while net loss narrowed by 73.33%, but EPS remained negative at HKD 0.0183, with a P/E of 439.19x. The stock is 81.14% below its 52-week high of HKD 24.44, trading below both its MA20 (4.853) and MA60 (5.861), and down 44.39% YTD, though the P/B ratio of 0.83x suggests undervaluation on a book value basis.

2522.HK opened lower at 4.50 HKD but staged a sharp intraday rebound, closing the morning session up 5.62% at 4.70 HKD, driven by a broader market recovery and improving fundamentals. The company reported a full-year net profit of 3.75 million RMB for 2025, turning around from losses, with Q4 revenue rising 22.37% YoY to 226 million HKD and net loss narrowing 73.33% to 7.06 million HKD. The stock initially touched a new 52-week low of 4.33 HKD (80.77% below the 52-week high of 24.44 HKD) before bouncing to the day's high of 4.70 HKD; total turnover was 2.35 million HKD on 517,500 shares traded (turnover rate 0.18%). Despite the rebound, the price remains below both the 20-day MA (4.947 HKD) and 60-day MA (6.098 HKD), with a YTD loss of 43.31% and a price-to-book ratio of 0.84x, though the company's trustee recently purchased 7.5 million shares on-market for a share award scheme, signaling insider confidence.

RIMAG Group (2522.HK) traded in a narrow range during the morning session, closing marginally up 0.6% at HKD 4.95, 79.8% below its 52-week high of HKD 24.44 and down 40.3% year-to-date. The stock hovered near the 5-day moving average but remained well below the 60-day MA of HKD 6.295, indicating a persistent weak long-term trend. On the news front, an on-market purchase of 7.5 million shares by a trustee for an award scheme signaled some insider confidence, while the company turned profitable for the full year 2025 with a net profit of RMB 3.75 million, and Q4 revenue rose 22.4% YoY to HKD 226 million with net loss narrowing 73.3%. However, the stock traded at a lofty PE of 471.6x and saw low turnover of just 1.13 million shares, reflecting thin liquidity.

Jiangxi Rimag closed down 0.8% at HKD 4.93 today, after briefly touching an intraday high of HKD 5.0 in the morning session, with the day's trading range between HKD 4.9 and 5.0. The decline was driven by renewed regulatory headwinds in the medical imaging sector, coupled with the company's ongoing turnaround despite improving fundamentals. While Q4 2025 revenue rose 22.37% YoY to HKD 225.8 million and net loss narrowed 73.33% YoY to HKD 7.06 million, the stock remains 79.83% below its 52-week high of HKD 24.44 and is down 40.53% year-to-date. TFI Asset Management reiterated a Buy rating but provided no specific target price. However, the stock's P/B ratio of 0.88x may attract value-oriented investors.